Categories: News

MagicMed Industries to present at the Planet MicroCap Showcase: Virtual on April 22nd

CALGARY, AB / ACCESSWIRE / April 20, 2021 / MagicMed Industries Inc. (“MagicMed” or the “Company“), a biotechnology company focused on creating novel psychedelic derivative molecules, today announced that Dr. Joseph Tucker, President and Chief Executive Officer, will be presenting a business and pipeline update at the LifeSciencesInvestorForum.com on April 22nd, 2021 as follows:

DATE: Thursday, April 22nd, 2021.
TIME: 2:00PM EST
LINK: https://www.webcaster4.com/Webcast/Page/2059/40839

This will be a live, interactive online event where investors are invited to ask the company questions in real-time. If attendees are not able to join the event live on the day of the conference, and archived webcast will also me made available after the event.

It is recommended that investors pre-register and run the online system check to expedite participation and receive event updates. Registration can be found at

https://planetmicrocapshowcase.com/signup.

Learn more about the event at https://planetmicrocapshowcase.com/.

About MagicMed

MagicMed Industries intends to partner with pharmaceutical and other companies to develop and commercialize psychedelic-derived pharmaceutical candidates. MagicMed’s psychedelic derivatives library, the PsybraryTM, is intended to be an essential building block from which the industry can develop new patented products. The initial focus of the PsybraryTM is on psilocybin and DMT derivatives, and the PsybraryTM is then expected to be expanded to other psychedelics such as MDMA, LSD, mescaline, and ibogaine.

About SNN, Network

SNN, Network is your multimedia financial news platform for discovery, transparency, and due diligence. This is your one-stop hub to find new investment ideas, check in on watchlist, gather the most up-to-date information on the Small-, Micro-, Nano-Cap market with the goal to help you towards achieving your wealth generation goals. Follow the companies YOU want to know more about; read and watch content from YOUR favorite finance and investing influencers; create YOUR own watchlist and screen for ideas YOU’RE interested in; find out about investor conferences YOU want to attend – all here on SNN Network.

MagicMed Industries Inc.
Dr. Joseph Tucker
President and Chief Executive Officer
403-605-8747

For further information, please contact MagicMed Industries Inc. Investor Relations at IR@magicmedindustries.com or visit our website at www.magicmedindustries.com.

Forward Looking Statements

This press release contains forward-looking statements. Forward-looking statements involve known and unknown risks, uncertainties and assumptions and accordingly, actual results and future events could differ materially from those expressed or implied in such statements. You are hence cautioned not to place undue reliance on forward-looking statements. All statements other than statements of present or historical fact are forward-looking statements, including, without limitation, statements with respect to MagicMed’s future business plans and partnerships, the anticipated uses of the PsybraryTM and the Company’s plans for the development of the PsybraryTM. Forward-looking statements include words or expressions such as “proposed”, “anticipated”, “will”, “subject to”, “near future”, “in the event”, “would”, “expect”, “prepared to” and other similar words or expressions.

Forward-looking statements are based on the opinions and estimates of management at the date the statements are made, and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those anticipated in the forward-looking statements. Some of the risks and other factors could cause results to differ materially from those expressed in the forward-looking statements which include, but are not limited to: the ability of MagicMed to secure patent protection; the regulatory environment in which MagicMed operates; the ability of MagicMed to enter into partnership agreements or other arrangements; the ability of MagicMed to carry out its business plans (including but not limited to its plans to file a prospectus and apply to list on a stock exchange); unforeseen challenges in carrying out such plans; the development and expansion of the PsybraryTM; trends in the future use of psilocybin; general business, economic, competitive, political and social uncertainties; the state of capital markets; risks relating to general economic, market and business conditions; and other unforeseen events, developments, or factors causing any of the aforesaid expectations, assumptions, and other factors ultimately being inaccurate or irrelevant. The forward-looking information contained in this news release is expressly qualified by this cautionary statement. We disclaim any obligation to update or revise these forward-looking statements, except as required by applicable law.

SOURCE: MariMed Inc.

View source version on accesswire.com:
https://www.accesswire.com/641209/MagicMed-Industries-to-present-at-the-Planet-MicroCap-Showcase-Virtual-on-April-22nd

Staff

Recent Posts

Judge Baker Children’s Center d/b/a The Baker Center for Children and Families Provides Notice of Data Security Incident

BOSTON, Dec. 27, 2024 /PRNewswire/ -- Judge Baker Children's Center d/b/a The Baker Center for…

4 hours ago

Glow Lifetech Grants Stock Options

Toronto, Ontario--(Newsfile Corp. - December 27, 2024) - Glow Lifetech Corp. (CSE: GLOW) (OTC Pink:…

10 hours ago

Inspira™ Announces Pricing of $3.2M Private Placement by New and Existing Investors of the Company

RA'ANANA, Israel, Dec. 27, 2024 /PRNewswire/ -- Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ: IINN), (NASDAQ:…

10 hours ago

In-Depth Analysis of BGM Group: Innovating Pharmaceuticals and Insurance through AI

CHONGQING, China, Dec. 27, 2024 /PRNewswire/ -- BGM Group Ltd. (Stock Code: BGM) has successfully acquired…

10 hours ago

NAVIGANTIS VASCO™ Robotic Platform Used with First Patients Enrolled in Neurovascular Study

MIAMI, Dec. 27, 2024 /PRNewswire/ -- Navigantis Inc. announced today the first successful neurovascular clinical cases…

10 hours ago

Biotricity Produces Largest Inventory in its History to Meet Accelerated Demand

Company Receives Capital Needed from its Term Lender and Existing Investors to Reach Profitability without…

10 hours ago